Arca Biopharma reported $54.92M in Assets for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Amgen AMGN:US $ 59294M 98M
Arca Biopharma ABIO:US $ 54.92M 14.26M
Biogen BIIB:US $ 25081.4M 1467M
Brainstorm Cell Therapeutics BCLI:US $ 25.79M 3.49M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Capricor Therapeutics CAPR:US $ 64.92M 23.59M
Cytokinetics CYTK:US $ 771.72M 84.54M
Cytrx CYTR:US 6.56M 2.16M
Daiichi Sankyo 4568:JP Y 2294549M 73147M
Gilead Sciences GILD:US $ 62870M 210M
GlaxoSmithKline GSK:LN 89045M 644M
Laboratory Of America LH:US $ 20403.1M 325.3M
Otsuka Holdings 4578:JP Y 3101281M 215253M
United Therapeutics UTHR:US $ 5543.3M 183.5M